Description
Anethole trithione is an oltipraz analog that is clinically used to treat xerostomia (dry mouth). Anethole trithione enhances salivary gland secretion.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Anethole trithione is an oltipraz analog that is clinically used to treat xerostomia (dry mouth). Anethole trithione enhances salivary gland secretion.
| Cas No. | 532-11-6 |
|---|---|
| Purity | ≥98% |
| Formula | C10H8OS3 |
| Formula Wt. | 240.37 |
| Chemical Name | 5-(4-Methoxyphenyl)-3H-1,2-dithiole-3-thione |
| IUPAC Name | 5-(4-methoxyphenyl)dithiole-3-thione |
| Synonym | Trithioanethole, ADT, Felviten, Mucinol, Sialor, Sulfarlem |
| Melting Point | 111°C |
| Solubility | Soluble in pyridine, chloroform, benzene, dioxane, and carbon disulfide. Slightly soluble in ether, acetone, ethyl acetate and cyclohexane. Practically insoluble in water. |
| Appearance | Orange Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Nagano T, Takeyama M. Enhancement of salivary secretion and neuropeptide (substance P, alpha-calcitonin gene-related peptide) levels in saliva by chronic anethole trithione treatment. J Pharm Pharmacol. 2001 Dec;53(12):1697-702. PMID: 11804400.
Hamada T, Nakane T, Kimura T, et al. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial. Am J Med Sci. 1999 Sep;318(3):146-51. PMID: 10487404.
Tyrosine kinase inhibitor.
JAK1/2/3 inhibitor.
V2 antagonist.
Nucleobase (adenine) analog; DNA polymerase inh...
TRPC5 activator, NS4B and histamine H1 inhibito...
HDAC inhibitor, mammalian RNA splicing modulato...
Peptidyl transferase inhibitor, protein transla...
CB1 agonist, TRPV1 agonist.
Synthetic somatostatin analog, peptide; somatos...
Thienopyridine; P2Y12 antagonist.
Synthetic steroid, contraceptive; PR and glucoc...
Nrf2-Keap1-ARE complex activator.
Aromatase inhibitor.
Benzophenanthridine alkaloid; topoisomerase I i...
Dual mTORC1/mTORC2 inhibitor.
Selective 5-HT6 receptor antagonist
NMDA NR1/NR2B antagonist.
NO donor; annexin A2 inhibitor.
Synthetic progestogen, orexigenic.
EZH2 inhibitor